spiperone (BioDeep_00000272938)

   


代谢物信息卡片


spiperone

  化学式: C23H26FN3O2 (395.2009)
中文名称: 螺哌隆
  谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F
InChI: InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29)


描述信息

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Spiperone is a potent dopamine D2, serotonin 5-HT1A, and serotonin 5-HT2A antagonist. Spiperone is a widely used pharmacological tool. Spiperone has the potential for the research of neurology diseases[1].

同义名列表

2 个代谢物同义名

spiperone; Spiroperidol



数据库引用编号

9 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Yuqi Wang, Jing Zhou, Fubing Zha, Mingchao Zhou, Dongxia Li, Qian Zheng, Shugeng Chen, Shuiping Yan, Xinling Geng, Jianjun Long, Li Wan, Yulong Wang. Comparative analysis of sleep parameters and structures derived from wearable flexible electrode sleep patches and polysomnography in young adults. Journal of neurophysiology. 2024 Apr; 131(4):738-749. doi: 10.1152/jn.00465.2023. [PMID: 38383290]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Sufang Liu, Yuanyuan Tang, Hui Shu, Delton Tatum, Qian Bai, Joshua Crawford, Ying Xing, Mary Kay Lobo, Larry Bellinger, Phillip Kramer, Feng Tao. Dopamine receptor D2, but not D1, mediates descending dopaminergic pathway-produced analgesic effect in a trigeminal neuropathic pain mouse model. Pain. 2019 Feb; 160(2):334-344. doi: 10.1097/j.pain.0000000000001414. [PMID: 30325872]
  • Xudong Cao, Yifang Zhang, Yin Chen, Yinli Qiu, Minquan Yu, Xiangqing Xu, Xin Liu, Bi-Feng Liu, Liangren Zhang, Guisen Zhang. Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics. Journal of medicinal chemistry. 2018 11; 61(22):10017-10039. doi: 10.1021/acs.jmedchem.8b01096. [PMID: 30383372]
  • Jakob A Shimshoni, Eyal Sobol, Ezekiel Golan, Yulius Ben Ari, Orit Gal. Pharmacokinetic and pharmacodynamic evaluation of 5-methoxy-2-aminoindane (MEAI): A new binge-mitigating agent. Toxicology and applied pharmacology. 2018 03; 343(?):29-39. doi: 10.1016/j.taap.2018.02.009. [PMID: 29458138]
  • Lisa S Robison, Mala Ananth, Michael Hadjiargyrou, David E Komatsu, Panayotis K Thanos. Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats. Journal of neural transmission (Vienna, Austria : 1996). 2017 05; 124(5):655-667. doi: 10.1007/s00702-017-1680-4. [PMID: 28116523]
  • Panayotis K Thanos, Ronald Kim, Foteini Delis, Mark J Rocco, Jacob Cho, Nora D Volkow. Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain. Behavioural brain research. 2017 03; 320(?):282-290. doi: 10.1016/j.bbr.2016.12.010. [PMID: 27993694]
  • Xue Liu, James C R Grove, Arlene A Hirano, Nicholas C Brecha, Steven Barnes. Dopamine D1 receptor modulation of calcium channel currents in horizontal cells of mouse retina. Journal of neurophysiology. 2016 08; 116(2):686-97. doi: 10.1152/jn.00990.2015. [PMID: 27193322]
  • Evgenii Germanovich Skurikhin, Olga Victorovna Pershina, Alena Mikhaylovna Reztsova, Natalia Nikolaevna Ermakova, Ekaterina Sergeevna Khmelevskaya, Vycheslav Andreevich Krupin, Inna Ernestovna Stepanova, Andrew Vladimirovich Artamonov, Andrew Alexandrovich Bekarev, Pavel Gennadjevich Madonov, Alexander Mikhaylovich Dygai. Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice. PloS one. 2015; 10(4):e0125065. doi: 10.1371/journal.pone.0125065. [PMID: 25927611]
  • André Mateus, Pär Matsson, Per Artursson. A high-throughput cell-based method to predict the unbound drug fraction in the brain. Journal of medicinal chemistry. 2014 Apr; 57(7):3005-10. doi: 10.1021/jm401963n. [PMID: 24601604]
  • E G Skurikhin, N N Ermakova, A M Reztsova, O V Pershina, E S Khmelevskaya, V A Krupin, I E Stepanova, V M Reztsova, D V Reihard, A V Artamonov, A A Bekarev, P G Madonov, D N Kinsht, V E Goldberg, A M Dygai. Anti-inflammatory and antifibrotic effects of a combination of spiperone and immobilized hyaluronidase on partially reversible and irreversible toxic pneumofibrosis. Bulletin of experimental biology and medicine. 2013 Nov; 156(1):53-8. doi: 10.1007/s10517-013-2276-0. [PMID: 24319728]
  • Daniel J Warner, Hongming Chen, Louis-David Cantin, J Gerry Kenna, Simone Stahl, Clare L Walker, Tobias Noeske. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals. 2012 Dec; 40(12):2332-41. doi: 10.1124/dmd.112.047068. [PMID: 22961681]
  • Magdalena Kozielska, Martin Johnson, Venkatesh Pilla Reddy, An Vermeulen, Cheryl Li, Sarah Grimwood, Rik de Greef, Geny M M Groothuis, Meindert Danhof, Johannes H Proost. Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats. Pharmaceutical research. 2012 Jul; 29(7):1932-48. doi: 10.1007/s11095-012-0722-8. [PMID: 22437487]
  • Paul Cumming. Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review. Synapse (New York, N.Y.). 2011 Sep; 65(9):892-909. doi: 10.1002/syn.20916. [PMID: 21308799]
  • Yasuto Kido, Pär Matsson, Kathleen M Giacomini. Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. Journal of medicinal chemistry. 2011 Jul; 54(13):4548-58. doi: 10.1021/jm2001629. [PMID: 21599003]
  • Beatriz Restrepo, Mónica García, Alicia Rodríguez-Barbero, Luis San Román, María Luisa Martin, Asunción Morán. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats. European journal of pharmacology. 2011 May; 659(1):37-44. doi: 10.1016/j.ejphar.2011.03.006. [PMID: 21414306]
  • Dove J Keith, Amy J Eshleman, Aaron Janowsky. Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins. European journal of pharmacology. 2011 Jan; 650(2-3):501-10. doi: 10.1016/j.ejphar.2010.10.023. [PMID: 20969853]
  • Fatemeh Talaei, Hjalmar R Bouma, Adrianus C Van der Graaf, Arjen M Strijkstra, Martina Schmidt, Robert H Henning. Serotonin and dopamine protect from hypothermia/rewarming damage through the CBS/H2S pathway. PloS one. 2011; 6(7):e22568. doi: 10.1371/journal.pone.0022568. [PMID: 21829469]
  • Jennifer Pfaffly, Michael Michaelides, Gene-Jack Wang, Jeffrey E Pessin, Nora D Volkow, Panayotis K Thanos. Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice. Synapse (New York, N.Y.). 2010 Jul; 64(7):503-10. doi: 10.1002/syn.20755. [PMID: 20175225]
  • Juan Zhen, Tamara Antonio, Aloke K Dutta, Maarten E A Reith. Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors. Journal of neuroscience methods. 2010 Apr; 188(1):32-8. doi: 10.1016/j.jneumeth.2010.01.031. [PMID: 20122961]
  • Michele Alves-Bezerra, David Majerowicz, Luciano A M Grillo, Hugo Tremonte, Caroline B Almeida, Glória R C Braz, Mauro Sola-Penna, Gabriela O Paiva-Silva, Katia C Gondim. Serotonin regulates an acyl-CoA-binding protein (ACBP) gene expression in the midgut of Rhodnius prolixus. Insect biochemistry and molecular biology. 2010 Feb; 40(2):119-25. doi: 10.1016/j.ibmb.2010.01.002. [PMID: 20079838]
  • Asunción Morán, Ana-Vega Ortiz de Urbina, María-Luisa Martín, Alicia Rodríguez-Barbero, Luis San Román. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats. European journal of pharmacology. 2009 Oct; 620(1-3):90-6. doi: 10.1016/j.ejphar.2009.08.026. [PMID: 19699736]
  • Takeshi Kumazawa, Koichi Saeki, Isao Yanagisawa, Seisaku Uchigasaki, Chika Hasegawa, Hiroshi Seno, Osamu Suzuki, Keizo Sato. Automated on-line in-tube solid-phase microextraction coupled with HPLC/MS/MS for the determination of butyrophenone derivatives in human plasma. Analytical and bioanalytical chemistry. 2009 Jun; 394(4):1161-70. doi: 10.1007/s00216-009-2774-0. [PMID: 19387622]
  • Asunción Morán, Ana-Vega Ortiz de Urbina, Maria-Luisa Martín, Mónica García, Alicia Rodriguez-Barbero, Fernando Dorado, Luis San Román. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat. European journal of pharmacology. 2008 Sep; 592(1-3):133-7. doi: 10.1016/j.ejphar.2008.06.106. [PMID: 18644367]
  • Adriana Lourenço da Silva, Juliana G Ferreira, Bárbara da Silva Martins, Sabrina Oliveira, Nathalia Mai, Domingos S Nunes, Elaine Elisabetsky. Serotonin receptors contribute to the promnesic effects of P. olacoides (Marapuama). Physiology & behavior. 2008 Sep; 95(1-2):88-92. doi: 10.1016/j.physbeh.2008.04.022. [PMID: 18561960]
  • Alejandra V Cahansky, Bibiana Kaiser Dutra, Daniela de Silva Castiglioni, Guendalina Turcato Oliveira, Georgina Bond Buckup, Enrique M Rodríguez. Induction of ovarian growth in Aegla platensis (Crustacea, Aeglidae) by means of neuroregulators incorporated to food. Revista de biologia tropical. 2008 Sep; 56(3):1201-7. doi: 10.15517/rbt.v56i3.5704. [PMID: 19419039]
  • Che Serguera, Viviana Triaca, Jakki Kelly-Barrett, Mumna Al Banchaabouchi, Liliana Minichiello. Increased dopamine after mating impairs olfaction and prevents odor interference with pregnancy. Nature neuroscience. 2008 Aug; 11(8):949-56. doi: 10.1038/nn.2154. [PMID: 18641644]
  • Ju-Heon Kim, Eun-Young Cho, Chengchun Min, Jae H Park, Kyeong-Man Kim. Characterization of functional roles of DRY motif in the 2nd intracellular loop of dopamine D2 and D3 receptors. Archives of pharmacal research. 2008 Apr; 31(4):474-81. doi: 10.1007/s12272-001-1181-x. [PMID: 18449505]
  • Anna-Lena Nordstrom, Mattias Mansson, Hristina Jovanovic, Per Karlsson, Christer Halldin, Lars Farde, Kimberly E Vanover, Uli Hacksell, Mark R Brann, Robert E Davis, David M Weiner. PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain. The international journal of neuropsychopharmacology. 2008 Mar; 11(2):163-71. doi: 10.1017/s1461145707007869. [PMID: 17708779]
  • Ji Yeon Han, Jung Sun Heo, Yun Jung Lee, Jang Hern Lee, Mary Taub, Ho Jae Han. Dopamine stimulates 45Ca2+ uptake through cAMP, PLC/PKC, and MAPKs in renal proximal tubule cells. Journal of cellular physiology. 2007 May; 211(2):486-94. doi: 10.1002/jcp.20956. [PMID: 17167784]
  • Jordi Camarasa, David Pubill, Elena Escubedo. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug. Brain research. 2006 Sep; 1111(1):72-82. doi: 10.1016/j.brainres.2006.06.087. [PMID: 16889759]
  • Marta Dziedzicka-Wasylewska, Agata Faron-Górecka, Joanna Andrecka, Agnieszka Polit, Maciej Kuśmider, Zygmunt Wasylewski. Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane. Biochemistry. 2006 Jul; 45(29):8751-9. doi: 10.1021/bi060702m. [PMID: 16846218]
  • Yasuhiko Higashi, Miyuki Kitahara, Youichi Fujii. Simultaneous analysis of haloperidol, its three metabolites and two other butyrophenone-type neuroleptics by high performance liquid chromatography with dual ultraviolet detection. Biomedical chromatography : BMC. 2006 Feb; 20(2):166-72. doi: 10.1002/bmc.547. [PMID: 16034821]
  • Hongxiang Lan, Curtiss J Durand, Martha M Teeter, Kim A Neve. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors. Molecular pharmacology. 2006 Jan; 69(1):185-94. doi: 10.1124/mol.105.017244. [PMID: 16236817]
  • Ihsan Ergün, M Cenk Akbostanci, Başol Canbakan, Bilge Koçer, Arzu Ensari, Gökhan Nergizoglu, Kenan Keven. Minimal change nephrotic syndrome with stiff-person syndrome: is there a link?. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2005 Jul; 46(1):e11-4. doi: 10.1053/j.ajkd.2005.03.009. [PMID: 15983949]
  • Chunhe Wang, David C Buck, Rui Yang, Tara A Macey, Kim A Neve. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases. Journal of neurochemistry. 2005 May; 93(4):899-909. doi: 10.1111/j.1471-4159.2005.03055.x. [PMID: 15857393]
  • Nathalie Bock, Gunther H Moll, Maike Wicker, Jürgen Pilz, Eckart Rüther, Tobias Banaschewski, Gerald Huether, Aribert Rothenberger. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. Pharmacopsychiatry. 2004 Jul; 37(4):163-7. doi: 10.1055/s-2004-827171. [PMID: 15467972]
  • Julie Y Crider, Gary W Williams, Colene D Drace, Parvaneh Katoli, Michelle Senchyna, Najam A Sharif. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells. Investigative ophthalmology & visual science. 2003 Nov; 44(11):4837-44. doi: 10.1167/iovs.02-1292. [PMID: 14578406]
  • Judith Varady, Xihan Wu, Xueliang Fang, Ji Min, Zengjian Hu, Beth Levant, Shaomeng Wang. Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach. Journal of medicinal chemistry. 2003 Oct; 46(21):4377-92. doi: 10.1021/jm030085p. [PMID: 14521403]
  • W S Flournoy, J S Wohl, T J Albrecht-Schmitt, D D Schwartz. Pharmacologic identification of putative D1 dopamine receptors in feline kidneys. Journal of veterinary pharmacology and therapeutics. 2003 Aug; 26(4):283-90. doi: 10.1046/j.1365-2885.2003.00494.x. [PMID: 12887611]
  • Geraldine B Sacca, Daniel A Sáenz, Carolina O Jaliffa, Luciana Minces, María I Keller Sarmiento, Ruth E Rosenstein. Photic regulation of heme oxygenase activity in the golden hamster retina: involvement of dopamine. Journal of neurochemistry. 2003 Apr; 85(2):534-42. doi: 10.1046/j.1471-4159.2003.01697.x. [PMID: 12675930]
  • Sung-Woon Choi, David R Elmaleh, Robert N Hanson, Timothy M Shoup, Alan J Fischman. Novel (bisarylmethoxy)butylpiperidine analogues as neurotransmitter transporter inhibitors with activity at dopamine receptor sites. Bioorganic & medicinal chemistry. 2002 Dec; 10(12):4091-102. doi: 10.1016/s0968-0896(02)00348-6. [PMID: 12413863]
  • Mark A Birrell, Natascia Crispino, David J Hele, Hema J Patel, Magdi H Yacoub, Peter J Barnes, Maria G Belvisi. Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD. British journal of pharmacology. 2002 Jun; 136(4):620-8. doi: 10.1038/sj.bjp.0704758. [PMID: 12055141]
  • Vikas Kumar, V K Khanna, P K Seth, P N Singh, S K Bhattacharya. Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn. Phytotherapy research : PTR. 2002 May; 16(3):210-6. doi: 10.1002/ptr.1101. [PMID: 12164263]
  • V A Evseev, O I Mikovskaia, L A Vetrilé, N A Trekova, L A Basharova, T G Khlopushina, M A Gruden'. [Dopamine antibodies as neuromodulators of behavioral reactions in mice of different genotypes]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova. 2002 May; 52(3):320-5. doi: NULL. [PMID: 12125398]
  • M D Jones, M E Williams, E J Hess. Expression of catecholaminergic mRNAs in the hyperactive mouse mutant coloboma. Brain research. Molecular brain research. 2001 Nov; 96(1-2):114-21. doi: 10.1016/s0169-328x(01)00281-9. [PMID: 11731016]
  • R M Edwards, D P Brooks. Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors. The Journal of pharmacology and experimental therapeutics. 2001 Sep; 298(3):1001-6. doi: NULL. [PMID: 11504796]
  • M He, E Sibille, D Benjamin, M Toth, T Shippenberg. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain research. 2001 May; 902(1):11-7. doi: 10.1016/s0006-8993(01)02271-5. [PMID: 11376590]
  • T L Thompson, S R Bridges, W J Weirs. Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment. Brain research bulletin. 2001 Apr; 54(6):631-8. doi: 10.1016/s0361-9230(01)00472-5. [PMID: 11403989]
  • M Eltze, H König, B Ullrich, T Grebe. Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors. European journal of pharmacology. 2001 Mar; 415(2-3):265-76. doi: 10.1016/s0014-2999(01)00835-4. [PMID: 11275009]
  • M Cyr, M Morissette, N Barden, S Beaulieu, J Rochford, T Di Paolo. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants. Neuroscience. 2001; 102(1):151-8. doi: 10.1016/s0306-4522(00)00444-9. [PMID: 11226678]
  • G L Alberts, J F Pregenzer, W B Im. Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH-SY5Y over human embryonic kidney 293 cells. British journal of pharmacology. 2000 Oct; 131(3):514-20. doi: 10.1038/sj.bjp.0703580. [PMID: 11015302]
  • K Ishizu, D F Smith, D Bender, E Danielsen, S B Hansen, D F Wong, P Cumming, A Gjedde. Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release. Synapse (New York, N.Y.). 2000 Oct; 38(1):87-101. doi: 10.1002/1098-2396(200010)38:1<87::aid-syn10>3.0.co;2-c. [PMID: 10941144]
  • M Scarselli, M Armogida, S Chiacchio, M G DeMontis, A Colzi, G U Corsini, R Maggio. Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments. European journal of pharmacology. 2000 Jun; 397(2-3):291-6. doi: 10.1016/s0014-2999(00)00272-7. [PMID: 10844126]
  • L Gazi, P Schoeffter, C Nunn, K Croskery, D Hoyer, D Feuerbach. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor. Naunyn-Schmiedeberg's archives of pharmacology. 2000 May; 361(5):555-64. doi: 10.1007/s002100000236. [PMID: 10832611]
  • L N Markova, N Iu Sakharova, V V Bezuglov. [The action of catecholamine-synthesis inhibitors and of spiperone on sea urchin and mouse embryos]. Ontogenez. 2000 Jan; 31(1):32-9. doi: NULL. [PMID: 10732361]
  • P R Albert, N Sajedi, S Lemonde, M H Ghahremani. Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists. The Journal of biological chemistry. 1999 Dec; 274(50):35469-74. doi: 10.1074/jbc.274.50.35469. [PMID: 10585418]
  • N Sartania, P G Strange. Role of conserved serine residues in the interaction of agonists with D3 dopamine receptors. Journal of neurochemistry. 1999 Jun; 72(6):2621-4. doi: 10.1046/j.1471-4159.1999.0722621.x. [PMID: 10349875]
  • A B Shapiro, K Fox, P Lam, V Ling. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. European journal of biochemistry. 1999 Feb; 259(3):841-50. doi: 10.1046/j.1432-1327.1999.00098.x. [PMID: 10092872]
  • A Murányi, P Gergely, M I Fekete, G M Nagy. Protein phosphatase 2A plays a role in the suckling-induced changes in the responsiveness of pituitary mammotropes. Endocrinology. 1998 Nov; 139(11):4590-7. doi: 10.1210/endo.139.11.6322. [PMID: 9794470]
  • W S Thomas, B S Neal-Beliveau, J N Joyce. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum. Brain research. Developmental brain research. 1998 Nov; 111(1):99-106. doi: 10.1016/s0165-3806(98)00126-6. [PMID: 9804909]
  • O Inoue, K Kobayashi, R Hosoi, A Gee. Opposing effects of clomipramine on [125I]RTI-55 and [3H]N-methylspiperone binding in mouse striatum: important role of other factors than endogenous dopamine?. Synapse (New York, N.Y.). 1998 Nov; 30(3):338-40. doi: 10.1002/(sici)1098-2396(199811)30:3<338::aid-syn12>3.0.co;2-w. [PMID: 9776138]
  • L Li, J A Schafer. Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct. The American journal of physiology. 1998 07; 275(1):F62-7. doi: 10.1152/ajprenal.1998.275.1.f62. [PMID: 9689005]
  • L D Van de Kar, A D Levy, Q Li, M S Brownfield. A comparison of the oxytocin and vasopressin responses to the 5-HT1A agonist and potential anxiolytic drug alnespirone (S-20499). Pharmacology, biochemistry, and behavior. 1998 Jul; 60(3):677-83. doi: 10.1016/s0091-3057(98)00025-2. [PMID: 9678651]
  • L Gazi, I Bobirnac, M Danzeisen, E Schüpbach, A T Bruinvels, S Geisse, B Sommer, D Hoyer, M Tricklebank, P Schoeffter. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. British journal of pharmacology. 1998 Jul; 124(5):889-96. doi: 10.1038/sj.bjp.0701921. [PMID: 9692773]
  • F Cantalamessa, P Barili, R Cavagna, M Sabbatini, G Tenore, F Amenta. Influence of neonatal treatment with the pyrethroid insecticide cypermethrin on the development of dopamine receptors in the rat kidney. Mechanisms of ageing and development. 1998 Jun; 103(2):165-78. doi: 10.1016/s0047-6374(98)00039-6. [PMID: 9701769]
  • P Barili, C Fringuelli, E Baldoni, F Mignini, D Zaccheo, F Amenta. Dopamine D2-like receptors in the kidney of spontaneously hypertensive rats: a radioligand binding assay and light microscope autoradiography study. Journal of autonomic pharmacology. 1998 Apr; 18(2):89-97. doi: 10.1046/j.1365-2680.1998.1820089.x. [PMID: 9730263]
  • D Berger, W Burkard, W Schaffner. Influence of Petasites hybridus on dopamine-D2 and histamine-H1 receptors. Pharmaceutica acta Helvetiae. 1998 Feb; 72(6):373-5. doi: ". [PMID: 9556437]
  • N Chairungsrilerd, K I Furukawa, T Ohta, S Nozoe, Y Ohizumi. Gamma-mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist. Naunyn-Schmiedeberg's archives of pharmacology. 1998 Jan; 357(1):25-31. doi: 10.1007/pl00005134. [PMID: 9459569]
  • F Liu, T Nesbitt, M K Drezner, P A Friedman, F A Gesek. Proximal nephron Na+/H+ exchange is regulated by alpha 1A- and alpha 1B-adrenergic receptor subtypes. Molecular pharmacology. 1997 Dec; 52(6):1010-8. doi: 10.1124/mol.52.6.1010. [PMID: 9415710]
  • P Barili, M Sabbatini, P Soares-da-Silva, F Amenta. Dopamine D2-like receptors in the rat kidney: effect of denervation. European journal of pharmacology. 1997 Sep; 334(2-3):233-40. doi: 10.1016/s0014-2999(97)01185-0. [PMID: 9369353]
  • G Tenore, P Barili, M Sabbatini, S K Tayebati, F Amenta. Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study. Mechanisms of ageing and development. 1997 Apr; 95(1-2):1-11. doi: 10.1016/s0047-6374(97)01864-2. [PMID: 9152957]
  • Y Watanabe, M Fujita, Y Ito, T Okada, H Kusuoka, T Nishimura. Brain dopamine transporter in spontaneously hypertensive rats. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1997 Mar; 38(3):470-4. doi: NULL. [PMID: 9074541]
  • D F Wong, G D Pearlson, L E Tune, L T Young, C C Meltzer, R F Dannals, H T Ravert, J Reith, M J Kuhar, A Gjedde. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 1997 Mar; 17(3):331-42. doi: 10.1097/00004647-199703000-00010. [PMID: 9119906]
  • P Hartvig, R Torstenson, J Tedroff, Y Watanabe, K J Fasth, P Bjurling, B Långström. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography. Journal of neural transmission (Vienna, Austria : 1996). 1997; 104(4-5):329-39. doi: 10.1007/bf01277655. [PMID: 9295169]
  • P Barbier, A Colelli, R Maggio, D Bravi, G U Corsini. Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration. Journal of neural transmission (Vienna, Austria : 1996). 1997; 104(8-9):867-74. doi: 10.1007/bf01285554. [PMID: 9451718]
  • V J Watts, K A Neve. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Molecular pharmacology. 1996 Oct; 50(4):966-76. doi: . [PMID: 8863843]
  • A M Paans, J Pruim, G P Smit, G Visser, A T Willemsen, K Ullrich. Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study. European journal of pediatrics. 1996 Jul; 155 Suppl 1(?):S78-81. doi: 10.1007/pl00014257. [PMID: 8828616]
  • T Takayasu, I Kakubari, A Fukamachi, E Mafune, N Takasugi, K Takayama, T Nagai. Determination of timiperone in rat plasma by high-performance liquid chromatography with electrochemical detection. Journal of chromatography. B, Biomedical applications. 1996 Apr; 679(1-2):161-5. doi: 10.1016/0378-4347(95)00586-2. [PMID: 8998556]
  • M Yang, A Srikiatkhachorn, M Anthony, B H Chong. Serotonin stimulates megakaryocytopoiesis via the 5-HT2 receptor. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 1996 Mar; 7(2):127-33. doi: 10.1097/00001721-199603000-00004. [PMID: 8735801]
  • M Kurashima, M Domae, T Inoue, M Nagashima, K Yamada, K Shirakawa, T Furukawa. Inhibitory effects of putative dopamine D3 receptor agonists, 7-OH-DPAT and quinpirole, on prolactin secretion in rats. Pharmacology, biochemistry, and behavior. 1996 Feb; 53(2):379-83. doi: 10.1016/0091-3057(95)02037-3. [PMID: 8808147]
  • K Shiosaki, P Jenner, K E Asin, D R Britton, C W Lin, M Michaelides, L Smith, B Bianchi, S Didomenico, L Hodges, Y Hong, L Mahan, J Mikusa, T Miller, A Nikkel, M Stashko, D Witte, M Williams. ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease. The Journal of pharmacology and experimental therapeutics. 1996 Jan; 276(1):150-60. doi: . [PMID: 8558425]
  • P Odou, G Vaiva, M Luyckx, C Brunet, T Dine, B Gressier, M Cazin, J C Cazin. Neuroleptic monitoring: relation between antipsychotic efficiency and radioreceptor assay of serum haloperidol. European journal of clinical pharmacology. 1996; 50(5):357-63. doi: 10.1007/s002280050123. [PMID: 8839656]
  • A L Nordström, L Farde, S Nyberg, P Karlsson, C Halldin, G Sedvall. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. The American journal of psychiatry. 1995 Oct; 152(10):1444-9. doi: 10.1176/ajp.152.10.1444. [PMID: 7573582]
  • R Rivest, P Falardeau, T Di Paolo. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain research. 1995 Sep; 692(1-2):269-72. doi: 10.1016/0006-8993(95)00611-s. [PMID: 8548314]
  • L H Claye, H C Akunne, M D Davis, S DeMattos, K F Soliman. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration. Molecular neurobiology. 1995 Aug; 11(1-3):55-66. doi: 10.1007/bf02740684. [PMID: 8561968]
  • S Rayport, D Sulzer. Visualization of antipsychotic drug binding to living mesolimbic neurons reveals D2 receptor, acidotropic, and lipophilic components. Journal of neurochemistry. 1995 Aug; 65(2):691-703. doi: 10.1046/j.1471-4159.1995.65020691.x. [PMID: 7616225]
  • P J Pauwels, C Palmier. Functional effects of the 5-HT1D receptor antagonist GR 127,935 at human 5-HT1D alpha, 5-HT1D beta, 5-HT1A and opossum 5-HT1B receptors. European journal of pharmacology. 1995 Jul; 290(2):95-103. doi: 10.1016/0922-4106(95)90021-7. [PMID: 8575538]
  • S Samnick, W Brandau, J Sciuk, A Steinsträsser, O Schober. Synthesis, characterization and biodistribution of neutral and lipid-soluble 99mTc-bisaminoethanethiol spiperone derivatives: possible ligands for receptor imaging with SPECT. Nuclear medicine and biology. 1995 Jul; 22(5):573-83. doi: 10.1016/0969-8051(95)00004-h. [PMID: 7581166]
  • A D Levy, Q Li, M Gustafson, L D Van de Kar. Neuroendocrine profile of the potential anxiolytic drug S-20499. European journal of pharmacology. 1995 Feb; 274(1-3):141-9. doi: 10.1016/0014-2999(94)00719-n. [PMID: 7768266]
  • C Coley, R Woodward, P Strange, L Naylor. Site-directed mutagenesis of conserved serine residues in the rat D2 dopamine receptor. Biochemical Society transactions. 1995 Feb; 23(1):94S. doi: 10.1042/bst023094s. [PMID: 7758814]
  • G McAllister, M R Knowles, S M Ward-Booth, H A Sinclair, S Patel, R Marwood, F Emms, S Patel, A Smith, G R Seabrook. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells. Journal of receptor and signal transduction research. 1995 Jan; 15(1-4):267-81. doi: 10.3109/10799899509045220. [PMID: 8903944]
  • R Maroto, M G López, M del Valle, J R Naranjo, B Mellström, A G García. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla. Molecular pharmacology. 1995 Jan; 47(1):40-50. doi: NULL. [PMID: 7838132]
  • R M Baldwin, Y Zea-Ponce, S S Zoghbi, M S al-Tikriti, J P Seibyl, E H Sybirska, R T Malison, M Laruelle, D S Charney, P B Hoffer. Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates. Nuclear medicine and biology. 1994 Oct; 21(7):969-76. doi: 10.1016/0969-8051(94)90087-6. [PMID: 9234352]
  • Y Fujishima, H Hara, M Shimazawa, K Yokota, T Sukamoto. [The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 1994 Jul; 104(1):19-29. doi: 10.1254/fpj.104.19. [PMID: 8076888]
  • O Gandolfi, R Rimondini, R Dall'Olio. D-cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain. Pharmacology, biochemistry, and behavior. 1994 Jun; 48(2):351-6. doi: 10.1016/0091-3057(94)90537-1. [PMID: 7916464]
  • M McHale, M C Coldwell, N Herrity, I Boyfield, F M Winn, S Ball, T Cook, J H Robinson, I S Gloger. Expression and functional characterisation of a synthetic version of the human D4 dopamine receptor in a stable human cell line. FEBS letters. 1994 May; 345(2-3):147-50. doi: 10.1016/0014-5793(94)00423-4. [PMID: 8200447]
  • S Escaf, C Cavallotti, A Ricci, J A Vega, F Amenta. Dopamine D1 and D2 receptors in the human ureter and urinary bladder: a radioligand binding and autoradiographic study. British journal of urology. 1994 May; 73(5):473-9. doi: 10.1111/j.1464-410x.1994.tb07629.x. [PMID: 8012766]